We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




New AI Approach Monitors Brain Health Using Passive Wearable Data

By HospiMedica International staff writers
Posted on 24 Mar 2026

Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. More...

Detecting early changes remains difficult in routine care and burdens specialty services as populations age. Researchers now report that data from smartwatches and smartphones can help monitor these fluctuations using artificial intelligence (AI). The approach aims to support earlier recognition of changes relevant to neurological and psychiatric care.

Researchers at The University of Geneva developed an IA approach that uses passively collected signals from a smartwatch and a dedicated smartphone app to assess day-to-day brain health. The system integrates heart rate, physical activity, sleep patterns, and contextual exposures. It is designed for continuous, noninvasive monitoring without altering daily routines. The goal is to anticipate short-term cognitive and emotional variability.

Eighty-eight volunteers aged 45 to 77 wore the devices for 10 months. The devices captured passive data across 21 indicators, including weather conditions and air pollution levels in addition to physiologic measures. Participants also provided “active” data every three months through standardized questionnaires assessing emotional state and cognitive performance tests. These active measures served as reference points for validating AI predictions.

After data collection, the passive signals were modeled with AI and compared against the questionnaire and test results. The average prediction error across outcomes was 12.5%. Emotional states were predicted more accurately than cognitive states, with error rates generally between 5% and 10% versus 10% to 20%, respectively.

Feature analyses indicated that air pollution, weather conditions, daily heart rate, and sleep variability were the most informative factors for cognitive outcomes. For emotional states, weather, sleep variability, and heart rate during sleep were most influential. These findings suggest that environmental and sleep-related inputs meaningfully contribute to short-horizon brain health forecasts.

The research was conducted across the Geneva School of Economics and Management’s Research Institute for Statistics and Information Science and the Faculty of Psychology and Educational Sciences’ Cognitive Aging Laboratory. It forms part of the joint faculty project Providemus alz. Results were published in npj Digital Medicine.

The next phase will extend monitoring to 24 months and examine characteristics linked to the highest- and lowest-performing AI models. The team indicates this could clarify real-world applicability for individualized monitoring. The approach may open avenues for earlier detection of abnormalities or changes in brain health.

"The aim was to determine whether AI could predict fluctuations in participants' cognitive and emotional health based on these data," said Igor Matias, doctoral assistant at the Research Institute for Statistics and Information Science at the Geneva School of Economics and Management at the University of Geneva and lead author of the study. "On average, the error rate was just 12.5%, opening up new possibilities for the use of connected devices in the early detection of abnormalities or changes in brain health".


Related Links
University of Geneva
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Gold Member
12-Channel ECG
CM1200B
Medical Adhesive
MED 5570U
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Credit: MedUni Wien/Houdek

New Surgical Technique Enlarges Aortic Root for Larger Valve Implantation

When replacing a diseased aortic valve, a small aortic root can prevent surgeons from implanting a prosthesis large enough for the patient’s body size. This can lead to patient-prosthesis mismatch, causing... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: The tool analyzes 3D time-of-flight MR angiography to measure brain vessel length, radius, volume, branching, tortuosity, and other structural features. (Photo courtesy of University of Rochester Medical Center)

MRI Tool Analysis Identifies Vascular Differences in Cerebral Small Vessel Disease

Cerebral small vessel disease (CSVD) involves changes or damage to the brain’s small blood vessels and is associated with stroke and cognitive impairment. Magnetic resonance imaging (MRI) can show cerebral... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.